URGN
URGN
NASDAQ · Biotechnology

Urogen Pharma Ltd

$24.75
-0.98 (-3.81%)
As of Nov 7, 1:54 AM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +83.3% upside
Low Target $37.53
Average Target $45.36
High Target $61.85
Current Price $24.75
Current
$24.75
Target
$45.36
$37.53 $45.36 avg $61.85
Scenario Analysis
Bear Case
$37.53
51.6%
Low target
Base Case
$45.36
+83.3%
Avg target
Bull Case
$61.85
+149.9%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$50.81
-51.3% from high
52-Week Low
$16.50
+50.0% from low
Target vs 52W High
$45.36
-10.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -40.7%